Molecular mechanisms of congenital hyperinsulinism

Journal of Molecular Endocrinology

Volumn 54, Issue 2, 2015, Pages R119-R129

  Rahman, Sofia A ^a   Nessa, Azizun ^a   Hussain, Khalid ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Congenital hyperinsulinism; Development; Genetics; Glucose; Human; Hypoglycaemia; Insulin; KATP channels

Indexed keywords

ADENOSINE TRIPHOSPHATE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MONOCARBOXYLATE TRANSPORTER 1; UNCOUPLING PROTEIN 2; INSULIN;

ABCC8 GENE; ATYPICAL CONGENITAL HYPERINSULINISM; BIOGENESIS; CELL FUNCTION; CHANNELOPATHY; DIABETES MELLITUS; DIFFUSE CONGENITAL HYPERINSULINISM; EXERCISE; FOCAL CONGENITAL HYPERINSULINISM; GCK GENE; GENE; GENE MUTATION; GLUD1 GENE; HISTOPATHOLOGY; HUMAN; HYPERAMMONEMIA; HYPERINSULINISM; INSULIN RELEASE; MOLECULAR GENETICS; PANCREAS ISLET BETA CELL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; REVIEW; SCHAD GENE; TURNOVER TIME; ANIMAL; BIOLOGICAL MODEL; GENETICS; PATHOLOGY; SECRETION (PROCESS);

ANIMALS; CONGENITAL HYPERINSULINISM; HUMANS; INSULIN; MODELS, BIOLOGICAL;

EID: 84929085950     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-15-0016     Document Type: Review

References (69)

1. Aynsley-Green A, Hussain K, Hall J, Saudubray JM, Nihoul-Fekete C, De Lonlay- Debeney P, Brunelle F, Otonkoski T, Thornton P & Lindley KJ 2000 Practical management of hyperinsulinismin infancy. Archives of Disease in Childhood. Fetal and Neonatal Edition 82 F98–F107. (doi:10.1136/fn.82.2.F98)
2. Bruining GJ 1990 Recent advances in hyperinsulinism and the pathogenesis of diabetes mellitus. Current Opinion in Pediatrics 2 758–765. (doi:10.1097/00008480-199008000-00024)
3. Chandran S, Peng FY, Rajadurai VS, Lu YT, Chang KT, Flanagan SE, Ellard S & Hussain K 2013 Paternally inherited ABCC8 mutation causing diffuse congenital hyperinsulinism. Endocrinology Diabetes & Metabolism Case Reports 2013 130041. (doi:10.1530/EDM-13-0041)
4. Cochrane WA, Payne WW, Simpkiss MJ & Woolf LI 1956 Familial hypoglycemia precipitated by amino acids. Journal of Clinical Investigation 35 411–422. (doi:10.1172/JCI103292)
5. Crane A & Aguilar-Bryan L 2004 Assembly, maturation, and turnover of KATP channel subunits. Journal of Biological Chemistry 279 9080–9090. (doi:10.1074/jbc.M311079200)
6. Damaj L, le Lorch M, Verkarre V, Werl C, Hubert L, Nihoul-Fekete C, Aigrain Y, de Keyzer Y, Romana SP, Bellanne-Chantelot C et al. 2008 Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. Journal of Clinical Endocrinology and Metabolism 93 4941–4947. (doi:10.1210/jc.2008-0673)
7. De Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ et al. 1997 Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. Journal of Clinical Investigation 100 802–807. (doi:10.1172/JCI119594)
8. Doupnik CA, Davidson N & Lester HA 1995 The inward rectifier potassium channel family. Current Opinion in Neurobiology 5 268–277. (doi:10.1016/0959-4388(95)80038-7)
9. Dunne MJ, Cosgrove KE, Shepherd RM, Aynsley-Green A & Lindley KJ 2004 Hyperinsulinism in infancy: from basic science to clinical disease. Physiological Reviews 84 239–275. (doi:10.1152/physrev.00022.2003)
10. Emre Y, Hurtaud C, Karaca M, Nubel T, Zavala F & Ricquier D 2007 Role of uncoupling protein UCP2 in cell-mediated immunity: how macrophage- mediated insulitis is accelerated in a model of autoimmune diabetes. PNAS 104 19085–19090. (doi:10.1073/pnas.0709557104)
11. Flanagan SE, Clauin S, Bellanne-Chantelot C, de Lonlay P, Harries LW, Gloyn AL & Ellard S 2009 Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Human Mutation 30 170–180. (doi:10.1002/humu.20838)
12. Flanagan SE, Kapoor RR, Mali G, Cody D, Murphy N, Schwahn B, Siahanidou T, Banerjee I, Akcay T, Rubio-Cabezas O et al. 2010 Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. European Journal of Endocrinology 162 987–992. (doi:10.1530/EJE-09-0861)
13. Gembal M, Gilon P & Henquin JC 1992 Evidence that glucose can control insulin release independently from its action on ATP-sensitive KC channels in mouse B cells. Journal of Clinical Investigation 89 1288–1295. (doi:10.1172/JCI115714)
14. Giblin JP, Quinn K & Tinker A 2002 The cytoplasmic C-terminus of the sulfonylurea receptor is important for KATP channel function but is not key for complex assembly or trafficking. European Journal of Biochemistry 269 5303–5313. (doi:10.1046/j.1432-1033.2002.03249.x)
15. Glaser B 2007 Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both? PLoS Medicine 4 e148. (doi:10.1371/journal.pmed.0040148)
16. Glaser B, Kesavan P, Heyman M, Davis E, Cuesta A, Buchs A, Stanley CA, Thornton PS, Permutt MA, Matschinsky FM et al. 1998 Familial hyperinsulinism caused by an activating glucokinase mutation. New England Journal of Medicine 338 226–230. (doi:10.1056/NEJM199801223380404)
17. Gonzalez-Barroso MM, Giurgea I, Bouillaud F, Anedda A, Bellanne- Chantelot C, Hubert L, de Keyzer Y, de Lonlay P & Ricquier D 2008 Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion. PLoS ONE 3 9. (doi:10.1371/journal.pone.0003850)
18. Goossens A, Gepts W, Saudubray JM, Bonnefont JP, Nihoul-Fekete , Heitz PU & Klöppel G 1989 Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. American Journal of Surgical Pathology 3 766–775. (doi:10.1097/00000478-198909000-00006)
19. Gremlich S, Nolan C, Roduit R, Burcelin R, Peyot ML, Delghingaro-Augusto V, Desvergne B , Michalik L, Prentki M & Wahli W 2005 Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor a transcriptional up-regulation of fatty acid oxidation. Endocrinology 146 375–382. (doi:10.1210/en.2004-0667)
20. Gupta RK, Vatamaniuk MZ, Lee CS, Flaschen RC, Fulmer JT, Matschinsky FM, Duncan SA & Kaestner KH 2005 The MODY1 gene HNF-4a regulates selected genes involved ininsulin secretion. Journal ofClinical Investigation 115 1006–1015. (doi:10.1172/JCI200522365)
21. Henquin JC, Nenquin M, Sempoux C, Guiot Y, Bellanne-Chantelot C, Otonkoski T, de Lonlay P, Nihoul-Fekete C & Rahier J 2011 In vitro insulin secretion by pancreatic tissue from infants with diazoxideresistant congenital hyperinsulinism deviates from model predictions. Journal of Clinical Investigation 121 3932–3942. (doi:10.1172/JCI58400)
22. Henquin JC, Sempoux C, Marchandise J, Godecharles S, Guiot Y, Nenquin M & Rahier J 2013 Congenital hyperinsulinism caused by hexokinase I expression or glucokinase-activating mutation in a subset of b-cells. Diabetes 62 1689–1696. (doi:10.2337/db12-1414)
23. Heslegrave AJ, Kapoor RR, Eaton S, Chadefaux B, Akcay T, Simsek E, Flanagan SE, Ellard S & Hussain K 2012 Leucine-sensitive hyperinsulinaemic hypoglycaemia in patients with loss of function mutations in 3-hydroxyacyl-CoA dehydrogenase. Orphanet Journal of Rare Diseases 7 25. (doi:10.1186/1750-1172-7-25)
24. Huopio H, Reimann F, Ashfield R, Komulainen J, Lenko H-L, Rahier J, Vauhkonen I, Kere J, Laakso M, Ashcroft F et al. 2000 Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. Journal of Clinical Investigation 106 897–906. (doi:10.1172/JCI9804)
25. Hussain K, Flanagan SE, Smith VV, Ashworth M, Day M, Pierro A & Ellard S 2008 An ABCC8 gene mutation and mosaic uniparental isodisomy resulting in atypical diffuse congenital hyperinsulinism. Diabetes 57 259–263. (doi:10.2337/db07-0998)
26. Inagaki N, Gonoi T, Clement JP, Namba N, Inazawa J, Gonzalez G, Aguilar- Bryan L, Seino S & Bryan J 1995 Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270 1166–1170. (doi:10.1126/science.270.5239.1166)
27. Kapoor RR, Flanagan SE, James CT, McKiernan J, Thomas AM, Harmer SC, Shield JP, Tinker A, Ellard S & Hussain K 2011 Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/ KCNJ11 mutations. Diabetologia 54 2575–2583. (doi:10.1007/s00125-011-2207-4)
28. Kapoor RR, Flanagan SE, Arya VB, Shield JP, Ellard S & Hussain K 2013 Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism. European Journal of Endocrinology 168 557–564. (doi:10.1530/EJE-12-0673)
29. Komatsu M, Schermerhorn T, Aizawa T & Sharp GW 1995 Glucose stimulation of insulin release in the absence of extracellular Ca2C and in the absence of any increase in intracellular Ca2C in rat pancreatic islets. PNAS 92 10728–10732. (doi:10.1073/pnas.92.23.10728)
30. Kuo CJ, Conley PB, Chen L, Sladek FM, Darnell JE Jr & Crabtree GR 1992 A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355 457–461. (doi:10.1038/355457a0)
31. Li C, Najafi H, Daikhin Y, Nissim IB, Collins HW, Yudkoff M, Matschinsky FM & Stanley CA 2003 Regulation of leucine-stimulated insulin secretion and glutamine metabolism in isolated rat islets. Journal of Biological Chemistry 278 2853–2858. (doi:10.1074/jbc.M210577200)
32. Li C, Chen P, Palladino A, Narayan S, Russell LK, Sayed S, Xiong G, Chen J, Stokes D, Butt YM et al. 2010 Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase. Journal of Biological Chemistry 285 31806–31818. (doi:10.1074/jbc.M110.123638)
33. MacMullen CM, Zhou Q, Snider KE, Tewson PH, Becker SA, Aziz AR, Ganguly A, Shyng S-L & Stanley CA 2011 Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the b-cell sulfonylurea receptor SUR1. Diabetes 60 1797–1804. (doi:10.2337/db10-1631)
34. Matschinsky FM 2002 Regulation of pancreatic b-cell glucokinase: from basics to therapeutics. Diabetes 51 (Suppl 3) S394–S404. (doi:10.2337/diabetes.51.2007.S394)
35. Matsuo M, Trapp S, Tanizawa Y, Kioka N, Amachi T, Oka Y, Ashcroft FM & Ueda K 2000 Functional analysis of a mutant sulfonylurea receptor, SUR1-R1420C, that is responsible for persistent hyperinsulinemic hypoglycemia of infancy. Journal of Biological Chemistry 275 41184–41191. (doi:10.1074/jbc.M006503200)
36. Miura A, Yamagata K, Kakei M, Hatakeyama H, Takahashi N, Fukui K, Nammo T, Yoneda K, Inoue Y, Sladek FM et al. 2006 Hepatocyte nuclear factor-4a is essential for glucose-stimulated insulin secretion by pancreatic b-cells. Journal of Biological Chemistry 281 5246–5257. (doi:10.1074/jbc.M507496200)
37. Nichols CG, Shyng S-L, Nestorowicz A, Glaser B, Clement JP, Gonzalez G, Aguilar-Bryan L, PermuttMA & Bryan J 1996 Adenosine diphosphate as an intracellular regulator of insulin secretion. Science 272 1785–1787. (doi:10.1126/science.272.5269.1785)
38. Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, Kere J & Sipila¨ I 2003 Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes 52 199–204. (doi:10.2337/diabetes.52.1.199)
39. Otonkoski T, Näntö-Salonen K, Seppänen M, Veijola R, Huopio H, Hussain K, Tapanainen P, Eskola O, Parkkola R, EkströmKet al. 2006 Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 55 13–18. (doi:10.2337/diabetes.55.01.06.db05-1128)
40. Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, Shield JP, Ellard S, Ferrer J & Hattersley AT 2007 Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Medicine 4 e118 0760–0769. (doi:10.1371/journal.pmed.0040118)
41. Pinney SE, MacMullen C, Becker S, Lin Y-W, Hanna C, Thornton P, Ganguly A, Shyng S-L & Stanley CA 2008 Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. Journal of Clinical Investigation 118 2877–2886. (doi:10.1172/JCI35414)
42. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P et al. 1998 Defective insulin secretion in hepatocyte nuclear factor 1a-deficient mice. Journal of Clinical Investigation 101 2215–2222. (doi:10.1172/JCI2548)
43. Pullen TJ, Sylow L, Sun G, Halestrap AP, Richter EA & Rutter GA 2012 Overexpression of monocarboxylate transporter-1 (Slc16a1) in mouse pancreatic b-cells leads to relative hyperinsulinism during exercise. Diabetes 61 1719–1725. (doi:10.2337/db11-1531)
44. Rahier J, Falt K, Muntefering H, Becker K, Gepts W & Falkmer S 1984 The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells? Diabetologia 26 282–289. (doi:10.1007/BF00283651)
45. Rahier J, Sempoux C, Fournet JC, Poggi F, Brunelle F, Nihoul-Fekete C, Saudubray JM & Jaubert F 1998 Partial or near-total pancreatectomy for persistent neonatal hyperinsulinaemic hypoglycaemia: the pathologist’s role. Histopathology 32 15–19. (doi:10.1046/j.1365-2559.1998.00326.x)
46. Rahier J, Guiot Y & Sempoux C 2000 Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Archives of Disease in Childhood. Fetal and Neonatal Edition 82 F108–F112. (doi:10.1136/fn.82.2.F108)
47. Saint-Martin C, Arnoux J-B, de Lonlay P & Bellanné-Chantelot C 2011 KATP channel mutations in congenital hyperinsulinism. Seminars in Pediatric Surgery 20 18–22. (doi:10.1053/j.sempedsurg.2010.10.012)
48. Santer R, Kinner M, Passarge M, Superti-Furga A, Mayatepek E, Meissner T, Schneppenheim R & Schaub J 2001 Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism–hyperammonemia syndrome. Human Genetics 108 66–71. (doi:10.1007/s004390000432)
49. Sekine N, Cirulli V, Regazzi R, Brown LJ, Gine E, Tamarit-Rodriguez J, Girotti M, Marie S, MacDonald MJ, Wollheim CB et al. 1994 Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic b-cells. Potential role in nutrient sensing. Journal of Biological Chemistry 269 4895–4902.
50. Sempoux C, Guiot Y, Lefevre A, Nihoul-Fekete C, Jaubert F, Saudubray JM & Rahier J 1998 Neonatal hyperinsulinemic hypoglycemia: heterogeneity of the syndrome and keys for differential diagnosis. Journal of Clinical Endocrinology and Metabolism 83 1455–1461. (doi:10.1210/jcem.83.5.4768)
51. Sempoux C, Guiot Y, Jaubert F & Rahier J 2004 Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis. Endocrine Pathology 15 241–246. (doi:10.1385/EP:15:3:241)
52. Sempoux C, Capito C, Bellanné-Chantelot C, Verkarre V, de Lonlay P, Aigrain Y, Fekete C, Guiot Y & Rahier J 2011 Morphological mosaicism of the pancreatic islets: a novel anatomopathological form of persistent hyperinsulinemic hypoglycemia of infancy. Journal of Clinical Endocrinology and Metabolism 96 3785–3793. (doi:10.1210/jc.2010-3032)
53. Sharma N, Crane A, Clement JP, Gonzalez G, Babenko AP, Bryan J & Aguilar-Bryan L 1999 The C terminus of SUR1 is required for trafficking of KATP channels. Journal of Biological Chemistry 274 20628–20632. (doi:10.1074/jbc.274.29.20628)
54. Shi Y, Avatapalle HB, Skae MS, Padidela R, Newbould M, Rigby L, Flanagan SE, Ellard S, Rahier J, Clayton PE et al. 2015 Increased plasma incretin concentrations identifies a subset of patients with persistent congenital hyperinsulinism without KATP channel gene defects. Journal of Pediatrics 166 191–194. (doi:10.1016/j.jpeds.2014.09.019)
55. Shilyansky J, Fisher S, Cutz E, Perlman K & Filler RM 1997 Is 95% pancreatectomy the procedure of choice for treatment of persistent hyperinsulinemic hypoglycemia of the neonate? Journal of Pediatric Surgery 32 342–346. (doi:10.1016/S0022-3468(97)90207-4)
56. Snider KE, Becker S, Boyajian L, Shyng S-L, MacMullen C, Hughes N, Ganapathy K, Bhatti T, Stanley CA & Ganguly A 2013 Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. Journal of Clinical Endocrinology & Metabolism 98 E355–E363. (doi:10.1210/jc.2012-2169)
57. Stanley CA, Lieu YK, Hsu BY, Burlina AB, Greenberg CR, Hopwood NJ, Perlman K, Rich BH, Zammarchi E & Poncz M 1998 Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. New England Journal of Medicine 338 1352–1357. (doi:10.1056/NEJM199805073381904)
58. Stanley CA, Fang J, Kutyna K, Hsu BY, Ming JE, Glaser B & Poncz M 2000 Molecular basis and characterization of the hyperinsulinism/ hyperammonemia syndrome: predominance of mutations in exons 11 and 12 of the glutamate dehydrogenase gene. HI/HA Contributing Investigators. Diabetes 49 667–673. (doi:10.2337/diabetes.49.4.667)
59. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S & McGarry JD 1996 Essentiality of circulating fatty acids for glucosestimulated insulin secretion in the fasted rat. Journal of Clinical Investigation 97 2728–2735. (doi:10.1172/JCI118727)
60. Sugden MC & Holness MJ 2004 Potential role of peroxisome proliferatoractivated receptor-a in the modulation of glucose-stimulated insulin secretion. Diabetes 53 (Suppl 1) S71–S81. (doi:10.2337/diabetes.53.2007.S71)
61. Sund NJ, Vatamaniuk MZ, Casey M, Ang SL, Magnuson MA, Stoffers DA, Matschinsky FM & Kaestner KH 2001 Tissue-specific deletion of Foxa2 in pancreatic b cells results in hyperinsulinemic hypoglycemia. Genes and Development 15 1706–1715. (doi:10.1101/gad.901601)
62. Taneja TK, Mankouri J, Karnik R, Kannan S, Smith AJ, Munsey T, Christesen HB, Beech DJ & Sivaprasadarao A 2009 Sar1-GTPasedependent ER exit of KATP channels revealed by a mutation causing congenital hyperinsulinism. Human Molecular Genetics 18 2400–2413. (doi:10.1093/hmg/ddp179)
63. Thornton PS, MacMullen C, Ganguly A, Ruchelli E, Steinkrauss L, Crane A, Aguilar-Bryan L & Stanley CA 2003 Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Diabetes 52 2403–2410. (doi:10.2337/diabetes.52.9.2403)
64. Tordjman K, Standley KN, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP & Semenkovich CF 2002 PPARa suppresses insulin secretion and induces UCP2 in insulinoma cells. Journal of Lipid Research 43 936–943.
65. Trapp S & Ashcroft FM 2000 Direct interaction of Na-azide with the KATP channel. British Journal of Pharmacology 131 1105–1112. (doi:10.1038/sj.bjp.0703680)
66. Treberg JR, Clow KA, Greene KA, Brosnan ME & Brosnan JT 2010 Systemic activation of glutamate dehydrogenase increases renal ammoniagenesis: implications for the hyperinsulinism/hyperammonemia syndrome. American Journal of Physiology. Endocrinology and Metabolism 298 E1219–E1225. (doi:10.1152/ajpendo.00028.2010)
67. Tucker SJ, Gribble FM, Zhao C, Trapp S & Ashcroft FM 1997 Truncation of Kir6.2 produces ATP-sensitive KC channels in the absence of the sulphonylurea receptor. Nature 387 179–183. (doi:10.1038/387179a0)
68. Weinzimer SA, Stanley CA, Berry GT, Yudkoff M, Tuchman M & Thornton PS 1997 A syndrome of congenital hyperinsulinism and hyperammonemia. Journal of Pediatrics 130 661–664. (doi:10.1016/S0022-3476(97)70256-7)
69. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal- Puig AJ, Boss O, Kim YB et al. 2001 Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, b cell dysfunction, and type 2 diabetes. Cell 105 745–755. (doi:10.1016/S0092-8674(01)00378-6)